Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome

被引:91
|
作者
Andrews, Shea J. [1 ]
Fulton-Howard, Brian [1 ]
O'Reilly, Paul [2 ,3 ]
Marcora, Edoardo [1 ]
Goate, Alison M. [1 ,2 ]
机构
[1] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, Dept Neurosci, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA
[3] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London, England
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
DISEASE; LOCI; METAANALYSIS; INFERENCE; ONSET;
D O I
10.1002/ana.25918
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective The purpose of this study was to infer causal relationships between 22 previously reported risk factors for Alzheimer's disease (AD) and the "AD phenome": AD, AD age of onset (AAOS), hippocampal volume, cortical surface area and thickness, cerebrospinal fluid (CSF) levels of amyloid-beta (A beta(42)), tau, and ptau(181), and the neuropathological burden of neuritic plaques, neurofibrillary tangles (NFTs), and vascular brain injury (VBI). Methods Polygenic risk scores (PRS) for the 22 risk factors were computed in 26,431 AD cases/controls and the association with AD was evaluated using logistic regression. Two-sample Mendelian randomization (MR) was used to infer the causal effect of risk factors on the AD phenome. Results PRS for increased education and diastolic blood pressure were associated with reduced risk for AD. MR indicated that only education was causally associated with reduced risk of AD, delayed AAOS, and increased cortical surface area and thickness. Total- and LDL-cholesterol levels were causally associated with increased neuritic plaque burden, although the effects were driven by single nucleotide polymorphisms (SNPs) within theAPOElocus. Diastolic blood pressure and pulse pressure are causally associated with increased risk of VBI. Furthermore, total cholesterol was associated with decreased hippocampal volume; smoking initiation with decreased cortical thickness; type 2 diabetes with an earlier AAOS; and sleep duration with increased cortical thickness. Interpretation Our comprehensive examination of the genetic evidence for the causal relationships between previously reported risk factors in AD using PRS and MR supports a causal role for education, blood pressure, cholesterol levels, smoking, and diabetes with the AD phenome. ANN NEUROL 2020
引用
收藏
页码:54 / 65
页数:12
相关论文
共 50 条
  • [1] Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease
    Luo, Jiao
    Thomassen, Jesper Qvist
    Bellenguez, Celine
    Grenier-Boley, Benjamin
    de Rojas, Itziar
    Castillo, Atahualpa
    Parveen, Kayenat
    Kuecuekali, Fahri
    Nicolas, Aude
    Peters, Oliver
    Schneider, Anja
    Dichgans, Martin
    Rujescu, Dan
    Scherbaum, Norbert
    Juergen, Deckert
    Riedel-Heller, Steffi
    Hausner, Lucrezia
    Porcel, Laura Molina
    Duezel, Emrah
    Grimmer, Timo
    Wiltfang, Jens
    Heilmann-Heimbach, Stefanie
    Moebus, Susanne
    Tegos, Thomas
    Scarmeas, Nikolaos
    Clarimon, Jordi
    Moreno, Fermin
    Perez-Tur, Jordi
    Bullido, Maria J.
    Pastor, Pau
    Sanchez-Valle, Raquel
    Alvarez, Victoria
    Boada, Merce
    Garcia-Gonzalez, Pablo
    Puerta, Raquel
    Mir, Pablo
    Real, Luis M.
    Pinol-Ripoll, Gerard
    Garcia-Alberca, Jose Maria
    Royo, Jose Luis
    Rodriguez-Rodriguez, Eloy
    Soininen, Hilkka
    Kuulasmaa, Teemu
    de Mendonca, Alexandre
    Mehrabian, Shima
    Hort, Jakub
    Vyhnalek, Martin
    van der Lee, Sven
    Graff, Caroline
    Papenberg, Goran
    JAMA NETWORK OPEN, 2023, 6 (05)
  • [2] Causal associations between modifiable risk factors and intervertebral disc degeneration
    Guo, Wei
    Li, Bao-Li
    Zhao, Jian-Yong
    Li, Xiao-Ming
    Wang, Lin-Feng
    SPINE JOURNAL, 2024, 24 (02): : 195 - 209
  • [3] Toward a Full Understanding of Causal and Modifiable Risk Factors for Alzheimer's Disease by Integrative Phenome-wide Association Studies
    Zhang, Deng-Feng
    Li, Ming
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : 756 - 758
  • [4] INVESTIGATING THE ROLE OF MODIFIABLE RISK FACTORS ON THE CAUSAL PATHWAY TO ALZHEIMER'S DISEASE
    Lord, Jodie
    Green, Rebecca
    Hubel, Christopher
    Richards, Marcus
    Sham, Pak
    Legido-Quigley, Cristina
    Dobson, Richard
    Proitsi, Petroula
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S132 - S132
  • [5] Causal associations between modifiable risk factors and pancreatitis: A comprehensive Mendelian randomization study
    Mao, Xiaotong
    Mao, Shenghan
    Sun, Hongxin
    Huang, Fuquan
    Wang, Yuanchen
    Zhang, Deyu
    Wang, Qiwen
    Li, Zhaoshen
    Zou, Wenbin
    Liao, Zhuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] ASSOCIATIONS BETWEEN POTENTIALLY MODIFIABLE RISK FACTORS AND ALZHEIMER DISEASE: A MENDELIAN RANDOMIZATION STUDY
    Ostergaard, Soren D.
    Mukherjee, Shubhabrata
    Sharp, Stephen J.
    Proitsi, Petroula
    Day, Felix
    Boehme, Kevin L.
    Walter, Stefan
    Kauwe, John S.
    Gibbons, Laura E.
    Larson, Eric B.
    Powell, John F.
    Langenberg, Claudia
    Crane, Paul K.
    Wareham, Nicholas J.
    Scott, Robert A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S166 - S167
  • [7] Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study
    Ostergaard, Soren D.
    Mukherjee, Shubhabrata
    Sharp, Stephen J.
    Proitsi, Petroula
    Lotta, Luca A.
    Day, Felix
    Perry, John R. B.
    Boehme, Kevin L.
    Walter, Stefan
    Kauwe, John S.
    Gibbons, Laura E.
    Larson, Eric B.
    Powell, John F.
    Langenberg, Claudia
    Crane, Paul K.
    Wareham, Nicholas J.
    Scott, Robert A.
    PLOS MEDICINE, 2015, 12 (06)
  • [8] Modifiable Risk Factors for Alzheimer's Disease
    Edwards, George A., III
    Gamez, Nazaret
    Escobedo, Gabriel, Jr.
    Calderon, Olivia
    Moreno-Gonzalez, Ines
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [9] Elucidating the link between the modifiable risk factors of Alzheimer's disease and neuroinflammation
    Schindler, Stephanie M.
    Klegeris, Andis
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (05) : 375 - 384
  • [10] Capitalising on modifiable risk factors for Alzheimer's disease
    Biessels, Geert Jan
    LANCET NEUROLOGY, 2014, 13 (08): : 752 - 753